Trilogy Capital Inc. Quest Diagnostics Inc Transaction History

Trilogy Capital Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$120.62 - $141.12 $49,333 - $57,718	-409 Reduced 19.62%	1,676 $231,000
Q3 2023 Oct 16, 2023	SELL	$121.86 - $144.92 $27,418 - $32,606	-225 Reduced 9.74%	2,085 $254,000
Q2 2023 Jul 24, 2023	BUY	$130.56 - $146.84 $8,225 - $9,250	63 Added 2.8%	2,310 $324,000
Q1 2023 Apr 17, 2023	BUY	$131.53 - $155.76 $53,927 - $63,861	410 Added 22.32%	2,247 $317,000
Q4 2022 Feb 09, 2023	BUY	$123.31 - $157.26 $226,520 - $288,886	1,837 New	1,837 $287,000
Q2 2019 Jul 11, 2019	SELL	$85.18 - $101.94 $192,932 - $230,894	-2,265 Closed	0 $0
Q1 2019 Apr 17, 2019	SELL	$80.68 - $89.92 $50,505 - $56,289	-626 Reduced 21.65%	2,265 $204,000
Q4 2018 Jan 15, 2019	SELL	$79.75 - $108.38 $43,623 - $59,283	-547 Reduced 15.91%	2,891 $241,000
Q3 2018 Oct 31, 2018	SELL	$105.42 - $114.99 $60,405 - $65,889	-573 Reduced 14.29%	3,438 $371,000
Q2 2018 Aug 20, 2018	SELL	$97.35 - $113.14 $57,047 - $66,300	-586 Reduced 12.75%	4,011 $441,000
Q1 2018 May 24, 2018	BUY	$96.42 - $107.88 $443,242 - $495,924	4,597 New	4,597 $461,000

925

95.1M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Trilogy Capital Inc. with notifications on news.